Brown Advisory Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,478
| Closed | -$216K | – | 23 |
|
|
2022
Q3 | $216K | Sell |
3,478
-5,663
| -62% | -$357K | 0.79% | 46 |
|
|
2022
Q2 | $566K | Sell |
9,141
-2,200
| -19% | -$136K | 0.53% | 48 |
|
|
2022
Q1 | $676K | Sell |
11,341
-6,100
| -35% | -$390K | 0.4% | 58 |
|
|
2021
Q4 | $1.26M | Sell |
17,441
-5,566
| -24% | -$383K | 0.54% | 46 |
|
|
2021
Q3 | $1.61M | Sell |
23,007
-8,280
| -26% | -$582K | 0.48% | 53 |
|
|
2021
Q2 | $2.15M | Buy |
31,287
+537
| +2% | +$35.9K | 0.34% | 58 |
|
|
2021
Q1 | $1.99M | Buy |
30,750
+11,881
| +63% | +$766K | 0.34% | 57 |
|
|
2020
Q4 | $1.1M | Sell |
18,869
-9,731
| -34% | -$587K | 0.19% | 82 |
|
|
2020
Q3 | $1.81M | Sell |
28,600
-1,610
| -5% | -$112K | 0.37% | 54 |
|
|
2020
Q2 | $2.33M | Buy |
30,210
+839
| +3% | +$64.3K | 0.5% | 48 |
|
|
2020
Q1 | $2.28M | Buy |
29,371
+7,332
| +33% | +$507K | 0.58% | 44 |
|
|
2019
Q4 | $1.43M | Sell |
22,039
-933
| -4% | -$60.8K | 0.34% | 68 |
|
|
2019
Q3 | $1.46M | Sell |
22,972
-801
| -3% | -$52.4K | 0.41% | 59 |
|
|
2019
Q2 | $1.61M | Buy |
23,773
+1,187
| +5% | +$78.1K | 0.43% | 55 |
|
|
2019
Q1 | $1.47M | Sell |
22,586
-269
| -1% | -$17.9K | 0.35% | 68 |
|
|
2018
Q4 | $1.45M | Sell |
22,855
-3,067
| -12% | -$214K | 0.28% | 78 |
|
|
2018
Q3 | $2M | Buy |
25,922
+827
| +3% | +$62.5K | 0.32% | 70 |
|
|
2018
Q2 | $1.78M | Sell |
25,095
-83
| -0.3% | -$5.86K | 0.31% | 77 |
|
|
2018
Q1 | $1.9M | Sell |
25,178
-1,443
| -5% | -$115K | 0.35% | 69 |
|
|
2017
Q4 | $1.91M | Buy |
26,621
+17,252
| +184% | +$1.31M | 0.37% | 70 |
|
|
2017
Q3 | $754K | Buy |
9,369
+505
| +6% | +$38.6K | 0.16% | 138 |
|
|
2017
Q2 | $628K | Sell |
8,864
-541
| -6% | -$36K | 0.14% | 160 |
|
|
2017
Q1 | $636K | Sell |
9,405
-3,175
| -25% | -$223K | 0.16% | 148 |
|
|
2016
Q4 | $904K | Buy |
12,580
+2,834
| +29% | +$211K | 0.25% | 98 |
|
|
2016
Q3 | $774K | Sell |
9,746
-453
| -4% | -$36.8K | 0.23% | 105 |
|
|
2016
Q2 | $856K | Sell |
10,199
-1,085
| -10% | -$96.3K | 0.27% | 91 |
|
|
2016
Q1 | $1.04M | Buy |
11,284
+315
| +3% | +$28.4K | 0.34% | 74 |
|
|
2015
Q4 | $1.1M | Sell |
10,969
-346
| -3% | -$36K | 0.38% | 71 |
|
|
2015
Q3 | $1.11M | Buy |
11,315
+153
| +1% | +$17K | 0.4% | 64 |
|
|
2015
Q2 | $1.31M | Buy |
11,162
+640
| +6% | +$69.9K | 0.44% | 54 |
|
|
2015
Q1 | $1.03M | Buy |
10,522
+3,716
| +55% | +$377K | 0.36% | 71 |
|
|
2014
Q4 | $643K | Buy |
6,806
+298
| +5% | +$30.8K | 0.23% | 108 |
|
|
2014
Q3 | $691K | Buy |
6,508
+749
| +13% | +$73.3K | 0.25% | 105 |
|
|
2014
Q2 | $480K | Buy |
+5,759
| New | +$448K | 0.17% | 146 |
|
Other funds holding GILD
Brown Advisory Securities's GILD Position: Q4 2022 in Review
Brown Advisory Securities sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 3,478 shares — an estimated $216K sold.
Brown Advisory Securities first reported a position in GILD in Q2 2014 and held it in 34 quarters. The position peaked at $2.33M in Q2 2020. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- Brown Advisory Securities reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
- Brown Advisory Securities sold 3,478 Gilead Sciences shares in Q4 2022, an estimated $216K.
- Brown Advisory Securities first reported a position in Gilead Sciences in Q2 2014 and held it in 34 quarters.
- Brown Advisory Securities's Gilead Sciences position peaked at $2.33M in Q2 2020.
- 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on Brown Advisory Securities's 13F filing for Q4 2022.